The ARIA-RISE project is a collaboration between the National Centre for Immunisation Research and Surveillance, Menzies School of Health Research and Timor-Leste Ministry of Health (MoH). It aims to provide information about the epidemiology of COVID-19 and other vaccine-preventable diseases by conducting serological surveillance in Timor-Leste.
The project will include three separate research studies, evaluating seroprevalence for SARS-CoV-2 and other vaccine preventable diseases in:
- Healthcare workers
- Residual blood samples from six municipalities in Timor-Leste
- Community members in a population-representative national serosurvey
Aims and objectives:
- Seroprevalence of SARS-CoV-2 infection assessed over time to inform public health policy to control and mitigate COVID-19 disease and inform potential COVID-19 immunisation strategies in Timor-Leste.
- Technical capacity to undertake serology at the Timor-Leste National Health Laboratory for SARS-CoV-2 and select vaccine preventable diseases is increased.
- The prevalence of immunity to select vaccine preventable diseases, including measles, rubella and hepatitis B, assessed to inform immunisation program policy and implementation
The project commenced in January 2021 and is due for completion in June 2022.
- Australian Government Department of Foreign Affairs and Trade
- ARIA: Australian Regional Immunisation Alliance
- Timor-Leste Ministry of Health (MoH)
- National Institute of Health (INS)
- National Centre for Immunisation Research and Surveillance (NCIRS)
- University of Sydney
- Integrated Crisis Management Centre (CIGC)
- World Health Organization (WHO)